Organon & Co reported $1.01 in EPS Earnings Per Share for its fiscal quarter ending in September of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q4 Dec/2025 0.76 0.90 Feb/12 2026
FY2025Q3 Sep/2025 1.01 0.94 0.87 Nov/10 2025
FY2025Q2 Jun/2025 1.00 0.94 1.12 Aug/05 2025
FY2025Q1 Mar/2025 1.02 0.96 1.22 May/01 2025
FY2024Q4 Dec/2024 0.90 0.94 0.88 Feb/13 2025




Eps Change Date
Bristol-Myers Squibb USD 1.63 0.17 Sep/2025
Celltrion KRW 1.13K 317.83 Sep/2025
Cspc Pharmaceutical CNY 0.08 0.01 Sep/2025
Dianthus Therapeutics USD -0.97 0.09 Sep/2025
Divis Laboratories Ltd INR 25.97 5.48 Sep/2025
Gilead Sciences USD 2.47 0.46 Sep/2025
Glaxosmithkline GBP 0.72 0.37 Sep/2025
Kangmei Pharma CNY 0 0 Sep/2025
Knight Therapeutics CAD -0.03 0.07 Jun/2025
Laboratorios Farma EUR 1.96 0.71 Dec/2023
Malin Corporation EUR 0 0 Dec/2024
Medical Developments International AUD 0 0 Jun/2025
Merck USD 2.04 0.54 Dec/2025
Neuren Pharmaceuticals AUD 0.06 0.97 Jun/2025
Novartis USD 2.02 0.04 Sep/2025
Organigram Holdings CAD -0.18 0.13 Sep/2025
Organon & Co USD 1.01 0.01 Sep/2025
Pharma Mar EUR -0.23 1.55 Sep/2025
Qiagen NV USD 0.53 0.07 Sep/2025
Sartorius EUR 1.26 0.63 Dec/2025
Sino Biopharmaceutical CNY 0.16 0.07 Jun/2025
Tilray USD -0.41 0.4 Dec/2025